MedPath

Inovobiologic Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Phase 3
Terminated
Conditions
Type II Diabetes Mellitus
Obesity
Interventions
Dietary Supplement: Rice Flour (placebo)
Dietary Supplement: PolyGlycopleX® - PGX®
First Posted Date
2012-07-19
Last Posted Date
2021-02-11
Lead Sponsor
InovoBiologic Inc.
Target Recruit Count
100
Registration Number
NCT01644201
Locations
🇨🇦

Wharton Medical Clinic and Weight Management Centre, Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath